BMO starts Ironwood at Market Perform

Not everyone is overly concerned with downside to Linzess estimates, despite downbeat commentary from Goldman and Mizuho.

BMO initiates Ironwood Pharmaceuticals (IRWD) at Market Perform.

Price target is $15, well above Goldman's $9.50 objective.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs